AdaptHealth (AHCO) Cash from Investing Activities (2018 - 2026)
AdaptHealth (AHCO) posted quarterly Cash from Investing Activities of -$204.5 million for Q1 2026, down 113.9% year-over-year from $1.5 billion in Q1 2025, and down 64.26% quarter-over-quarter from -$124.5 million in Q4 2025.
AdaptHealth (AHCO) Cash from Investing Activities (2018 - 2026) Analysis & Trends
AdaptHealth's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$204.5 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 113.9% year-over-year to -$204.5 million; the TTM figure through Mar 2026 stood at -$412.1 million (down 29.59% YoY), while the FY2025 annual figure was -$303.2 million, up 2.28% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$204.5 million, down from -$124.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $9.6 million in Q2 2025, with the low at -$204.5 million in Q1 2026.
- The 5-year median for Cash from Investing Activities is -$89.9 million (2022), against an average of -$93.3 million.
- The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities surged 111.82% in 2025, then slumped 113.9% in 2026.
- AdaptHealth's Cash from Investing Activities stood at -$145.8 million in 2022, then surged by 37.98% to -$90.4 million in 2023, then grew by 3.92% to -$86.9 million in 2024, then slumped by 43.28% to -$124.5 million in 2025, then plunged by 64.26% to -$204.5 million in 2026.
- Business Quant data shows AHCO's Cash from Investing Activities at -$204.5 million in Q1 2026, -$124.5 million in Q4 2025, and -$92.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | AdaptHealth | 730.28 Mn | 686.99 Mn | 104.21 Mn | -202.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -202.71 Mn |
| Jun 30, 2026 | -202.71 Mn |
| Mar 31, 2026 | -204.46 Mn |
| Mar 31, 2026 | -204.46 Mn |
| Dec 31, 2025 | -124.47 Mn |
| Dec 31, 2025 | -124.47 Mn |
| Sep 30, 2025 | -92.74 Mn |
| Sep 30, 2025 | -92.74 Mn |
| Jun 30, 2025 | 9.60 Mn |
| Jun 30, 2025 | 9.60 Mn |
| Mar 31, 2025 | -95.59 Mn |
| Mar 31, 2025 | -95.59 Mn |
| Dec 31, 2024 | -86.87 Mn |
| Dec 31, 2024 | -86.87 Mn |
| Sep 30, 2024 | -54.24 Mn |
| Sep 30, 2024 | -54.24 Mn |
| Jun 30, 2024 | -81.27 Mn |
| Jun 30, 2024 | -81.27 Mn |
| Mar 31, 2024 | -87.89 Mn |
| Mar 31, 2024 | -87.89 Mn |